News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Moberg Derma and Paladin Labs Inc. (CC:PLB) Extends Agreement for Kerasal™ Nail to Mexico


5/13/2013 9:36:33 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Moberg Pharma AB (OMX: MOB) today announced that Paladin has been granted the exclusive rights to market and sell Kerasal Nailâ„¢ in Mexico. Kerasal Nailâ„¢ is an over-the-counter (OTC), topical product with a unique mechanism of action that generates visible improvements within 2-4 weeks of treatment. Further details or financial terms of the transaction were not disclosed.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES